AstraZeneca’s Cancer Drug Trial Disappoints, Sending Shares Lower
Thursday, July 27, 2017 - 06:02
in Health & Medicine
The treatment had been expected to be a crucial driver of growth for the company as it faces more competition from generic pharmaceuticals.